DADLE
Appearance
| Names | |
|---|---|
| IUPAC name
(2R)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid | |
| Other names
• [D-Ala2, D-Leu5]-Enkephalin • L-Tyrosyl-D-alanylglycyl-L-phenylalanyl-D-Leucine • N-(N-(N-(N-L-tyrosyl-D-alanyl)glycyl)-L-phenylalanyl)-D-Leucine • Tyr-D-Ala-Gly-Phe-D-Leu-OH | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.059.337 |
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C29H39N5O7 | |
| Molar mass | 569.659 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
DADLE ([D-Ala2, D-Leu5]-Enkephalin) is a synthetic opioid peptide with analgesic properties. It activates the δ-opioid receptor.[1]
Treatment with DADLE results in transient depression of mean arterial blood pressure and heart rate.[2][3]
See also
[edit]References
[edit]- ↑ Mobbs, Jesse I.; Nguyen, M. Deborah; Deo, Owindeep; Bartuzi, Damian; Venugopal, Hariprasad; Alvi, Sadia; Pham, Vi; Barnes, Nicholas; Christopoulos, Arthur; Poole, Daniel P.; Carbone, Simona E.; Jörg, Manuela; Capuano, Ben; Carlsson, Jens; Gondin, Arisbel B. (2026-08-22). "Structure-guided allosteric modulation of the delta opioid receptor". Nature Communications. doi:10.1038/s41467-026-76730-x. ISSN 2041-1723.
- ↑ "Medical Dictionary Online". Archived from the original on 2007-08-28. Retrieved 2007-11-10.
- ↑ Online Medical Dictionary, enkephalin, leucine-2-alanine[link removed]
